For further information and to discuss investment opportunities, please contact our CEO Lauren Barber.
Established by clinical nurse specialists in partnership with Vestech Medical and with the support of MedTech Actuator, we’re working to bring a product to market in all areas of clinical practice where hypodermic needles are used.
Currently in the final stages of development, our technology is expected to be commercially available in Australia from early 2020.
NeedleCalm is proudly funded by the NSW Government.
NeedleCalm Pty Ltd has been supported by a number of industry leading partners including: